scholarly journals A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance

Cancer ◽  
2014 ◽  
Vol 120 (16) ◽  
pp. 2448-2456 ◽  
Author(s):  
Alberto S. Pappo ◽  
Gilles Vassal ◽  
John J. Crowley ◽  
Vanessa Bolejack ◽  
Pancras C. W. Hogendoorn ◽  
...  
Cancer ◽  
2019 ◽  
Vol 125 (14) ◽  
pp. 2445-2454 ◽  
Author(s):  
Robin L. Jones ◽  
Sant P. Chawla ◽  
Steven Attia ◽  
Patrick Schöffski ◽  
Hans Gelderblom ◽  
...  

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 11019-11019 ◽  
Author(s):  
Brian Andrew Van Tine ◽  
Mark Agulnik ◽  
Richard D. Olson ◽  
Gerald M. Walsh ◽  
Arthur Klausner ◽  
...  

Author(s):  
Maria Leticia Gobo Silva ◽  
Celso Abdon Lopes de Mello ◽  
Samuel Aguiar ◽  
Felipe D́Almeida Costa ◽  
Paulo Roberto Stevanato Filho ◽  
...  

2004 ◽  
Vol 444 (2) ◽  
pp. 142-148 ◽  
Author(s):  
Jia-Lin Yang ◽  
Lill-Tove R. Busund ◽  
Kim T. Ow ◽  
Pamela Russell ◽  
Philip J. Crowe

2012 ◽  
Vol 48 (16) ◽  
pp. 3027-3035 ◽  
Author(s):  
Irène Asmane ◽  
Emmanuel Watkin ◽  
Laurent Alberti ◽  
Adeline Duc ◽  
Perrine Marec-Berard ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document